NicoDerm CQ Does Not Require Doctor Appointment To Quit Smoking - Ad
This article was originally published in The Tan Sheet
Executive Summary
A new TV ad for SmithKline Beecham's NicoDerm CQ OTC transdermal nicotine smoking cessation patch focuses on the product's OTC availability as an advantage over Rx smoking cessation aids.
You may also be interested in...
Glaxo SmithKline OTC Switch Potential Seen As Merger Catalyst
The Rx influenza treatment Relenza tops the list of potential OTC switch candidates in the Glaxo SmithKline portfolio, according to merger details announced the week of Jan. 17.
Glaxo SmithKline OTC Switch Potential Seen As Merger Catalyst
The Rx influenza treatment Relenza tops the list of potential OTC switch candidates in the Glaxo SmithKline portfolio, according to merger details announced the week of Jan. 17.
Glaxo SmithKline OTC Switch Potential Seen As Merger Catalyst
The Rx influenza treatment Relenza tops the list of potential OTC switch candidates in the Glaxo SmithKline portfolio, according to merger details announced the week of Jan. 17.